Skip to main content
Caplight Logo









Cellweaverse

Cellweaverse

Private
PohangHealthcare & Life Scienceshttps://cellweaverse.com

Last Round

Grant

Mar 27, 2026

Total Funding Raised

$790,000

Company Overview

Cellweaverse is a biotechnology company that develops and produces animal-derived materials without using animals through its cell culture technology for the pharmaceutical, medical, food, and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Compliance

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

cell cultureendotoxin testingbiomaterialslab-grown materialslimulus amoebocyte lysateLALcellular microenvironmentbiotech R&Dsynthetic biologyanimal-free testingheparin alternativebioprocessingAI-driven bioprocessingclean meat tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellweaverse Comparables

Compare Cellweaverse with similar companies based on industry and business-model similarity.

Cellweaverse comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Huzhou Shenke Biotechnology Co., Ltd.
76%
SEIKAGAKU CORPORATION
74%
Charles River Laboratories
73%

Cellweaverse Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 27, 2026
SeedNov 22, 2024
GrantNov 1, 2024

Cellweaverse Investors

Notable investors and investment history

Cellweaverse investors
InvestorRounds
POSTECH Holdings Co., Ltd.Seed
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 22, 2024

    POSTECH Holdings Co., Ltd. participated in the Seed round.

  • Nov 1, 2024

    $360K awarded by the Government of South Korea.

Cellweaverse Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellweaverse Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellweaverse's valuation, stock price, and market status.

Firmographic Details

HeadquartersPohang
Year Founded2024
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?